Semaglutide, tirzepatide, and other GLP-1-based therapies may help appropriate patients achieve meaningful weight loss, but long-term results depend on what happens next: follow-up, strength, protein, hydration, lab monitoring, dose review, and realistic planning
However, many researchers are concerned about potential ocular adverse effects with continued use of these medications, most notoriously the controversy about a potential increased risk of ischemic optic neuropathy that has generated several research papersoften contradictorysince last summer
SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week Are GLP-1 Patches Next
Our clinical experience has taught us that most patients tolerate the medications well the proper dosing protocols in place and proper management of adverse effects